Effectiveness of progesterone, cerclage and pessary for preventing preterm birth in singleton pregnancies: a systematic review and network meta-analysis

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 124, Issue 8, 2017, Pages 1176-1189

  Jarde, A ^a   Lutsiv, O ^a   Park, C K ^a   Beyene, J ^a   Dodd, J M ^b   Barrett, J ^c   Shah, P S ^d   Cook, J L ^e,f   Saito, S ^g   Biringer, A B ^h   Sabatino, L ⁱ   Giglia, L ^a   Han, Z ^j   Staub, K ^k   Mundle, W ^l   Chamberlain, J ^m   McDonald, S D ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e The Society of Obstetricians and Gynaecologists of Canada   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITY OF TOYAMA   (Japan)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ MCMASTER UNIVERSITY   (Canada)

^j THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^k Canadian Premature Babies Foundation   (Canada)

^l WINDSOR REGIONAL HOSPITAL   (Canada)

^m UGANDA CHRISTIAN UNIVERSITY   (Uganda)

more..

Author keywords

Cervical cerclage; cervical pessary; network meta analysis; preterm birth; progesterone; systematic review

Indexed keywords

PROGESTERONE; GESTAGEN;

BAYES THEOREM; CLINICAL EFFECTIVENESS; HUMAN; META ANALYSIS; NUMBERS NEEDED TO TREAT; OUTCOME ASSESSMENT; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VAGINA PESSARY; ADULT; COMPARATIVE STUDY; FEMALE; GESTATIONAL AGE; INTRAVAGINAL DRUG ADMINISTRATION; NETWORK META-ANALYSIS; NEWBORN; PREMATURITY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UTERINE CERVIX CERCLAGE;

ADMINISTRATION, INTRAVAGINAL; ADULT; BAYES THEOREM; CERCLAGE, CERVICAL; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; NETWORK META-ANALYSIS; PESSARIES; PREGNANCY; PREMATURE BIRTH; PROGESTERONE; PROGESTINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 85017560421     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.14624     Document Type: Review

References (65)

1. World Health Organization. Fact sheet No. 363—Preterm birth [Internet]: World Health Organization; 2014 [www.who.int/mediacentre/factsheets/fs363/en/]. Accessed 25 September 2015.
2. Behrman RE, Butler AS. Preterm Birth: Causes, Consequences, and Prevention. Washington, DC: National Academies Press, 2007.
3. Dodd JM, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev 2013;7:CD004947.
4. Alfirevic Z, Stampalija T, Roberts D, Jorgensen AL. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database Syst Rev 2012;4:CD008991.
5. Abdel-Aleem H, Shaaban OM, Abdel-Aleem MA. Cervical pessary for preventing preterm birth. Cochrane Database Syst Rev 2013;5:CD007873.
6. Farine D, Mundle W, Dodd J, Basso M, Delisle M, Grabowska K, et al. The use of progesterone for prevention of preterm birth. JOGC 2008;30:67–77.
7. Brown R, Gagnon R, Delisle M, Bujold E, Basso M, Bos H, et al. Cervical insufficiency and cervical cerclage. JOGC 2013;35:1115–27.
8. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No.142: cerclage for the management of cervical insufficiency. Obstet Gynecol 2014;123:372–9.
9. Shennan AH, To MS. Green-top Guideline No 60: Cervical Cerclage. London: RCOG, 2011.
10. Committee on Practice Bulletins—Obstetrics T. Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol 2012;120:964.
11. Sarri G, Davies M, Gholitabar M, Norman JE. Preterm labour: summary of NICE guidance. BMJ 2015;351:h6283.
12. Committee SfM-FMP. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. Am J Obstet Gynecol 2012;206:376–86.
13. Salanti G, Higgins JP, Ades A, Ioannidis JP. Evaluation of networks of randomized trials. Stat Methods Med Res 2008;17:279–301.
14. Andrews WW, Copper R, Hauth JC, Goldenberg RL, Neely C, DuBard M. Second-trimester cervical ultrasound: associations with increased risk for recurrent early spontaneous delivery. Obstet Gynecol 2000;95:222–6.
15. Jarde A, Lutsiv O, Park C, Barrett J, Beyene J, Saito S, et al. Preterm birth prevention in twin pregnancies with progesterone, pessary, or cerclage: a systematic review and meta-analysis. BJOG 2017; Feb.8 Epub ahead of print.
16. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions 5.1.0 [updated March 2011]: The Cochrane Collaboration; 2011. [www.cochrane-handbook.org].
17. Jansen JP, Crawford B, Bergman G, Stam W. Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value in Health 2008;11:956–64.
18. Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences. Stat Sci 1992;7:457–72.
19. Puhan MA, Schünemann HJ, Murad MH, Li T, Brignardello-Petersen R, Singh JA, et al. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ 2014;349:g5630.
20. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557–60.
21. van Valkenhoef G, Dias S, Ades A, Welton NJ. Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis. Res Synth Methods 2016;7:80–93.
22. Salanti G, Ades A, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol 2011;64:163–71.
23. vanValkenhoef G, Kuiper J. gemtc: Network Meta-Analysis Using Bayesian Methods. R package version 0.6-2 ed2015.
24. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455–63.
25. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002.
26. Romero R, Stanczyk FZ. Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice. Am J Obstet Gynecol 2013;208:421.
27. Johnson JW, Austin KL, Jones GS, Davis GH, King TM. Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med 1975;293:675–80.
28. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003;188:419–24.
29. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17 α-hydroxyprogesterone caproate.[Erratum appears in N Engl J Med 2003;349:1299]. N Engl J Med 2003;348:2379–85.
30. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Fetal Medicine Foundation Second Trimester Screening G. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007;357:462–9.
31. O'Brien JM, Adair CD, Lewis DF, Hall DR, Defranco EA, Fusey S, et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007;30:687–96.
32. Akbari S, Birjandi M, Mohtasham N. Evaluation of the effect of progesterone on prevention of preterm delivery and its complications. Scientific J Kurdistan Univ Med Sci 2009;14:11–19.
33. Majhi P, Bagga R, Kalra J, Sharma M. Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India. J Obstet Gynaecol 2009;29:493–8.
34. Rai P, Rajaram S, Goel N, Ayalur Gopalakrishnan R, Agarwal R, Mehta S. Oral micronized progesterone for prevention of preterm birth. Int J Gynaecol Obstet 2009;104:40–3.
35. Ibrahim M, Mohamed Ramy AR, Younis MAF. Progesterone supplementation for prevention of preterm labor: a randomized controlled trial. Middle East Fertil Soc J 2010;15:39–41.
36. Cetingoz E, Cam C, Sakalli M, Karateke A, Celik C, Sancak A. Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial. Arch Gynecol Obstet 2011;283:423–9.
37. Glover MM, McKenna DS, Downing CM, Smith DB, Croom CS, Sonek JD. A randomized trial of micronized progesterone for the prevention of recurrent preterm birth. Am J Perinatol 2011;28:377–81.
38. Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011;38:18–31.
39. Saghafi N, Khadem N, Mohajeri T, Shakeri MT. Efficacy of 17alpha-hydroxyprogesterone caproate in prevention of preterm delivery. J Obstet Gynaecol Res 2011;37:1342–5.
40. Grobman WA, Thom EA, Spong CY, Iams JD, Saade GR, Mercer BM, et al. 17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. Am J Obstet Gynecol 2012;207:e1–8.
41. van Os MA, van der Ven AJ, Kleinrouweler CE, Schuit E, Kazemier BM, Verhoeven CJ, et al. Preventing preterm birth with progesterone in women with a short cervical length from a low-risk population: a multicenter double-blind placebo-controlled randomized trial. Am J Perinatol 2015;32:993–1000.
42. Winer N, Bretelle F, Senat M-V, Bohec C, Deruelle P, Perrotin F, et al. 17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial. Am J Obstet Gynecol 2015;212:485. e1–485. e10.
43. Norman JE, Marlow N, Messow C-M, Shennan A, Bennett PR, Thornton S, et al. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial. The Lancet 2016;387:2106–16.
44. Lazar P, Gueguen S, Dreyfus J, Renaud R, Pontonnier G, Papiernik E. Multicentred controlled trial of cervical cerclage in women at moderate risk of preterm delivery. Br J Obstet Gynaecol 1984;91:731–5.
45. Rush RW, Isaacs S, McPherson K, Jones L, Chalmers I, Grant A. A randomized controlled trial of cervical cerclage in women at high risk of spontaneous preterm delivery. Br J Obstet Gynaecol 1984;91:724–30.
46. Szeverenyi M, Chalmels J, Grant A, Nagy T, Nagy J, Balogh I, et al. Surgical cerclage in the treatment of cervical incompetence during pregnancy (determining the legitimacy of the procedure). Orv Hetil 1992;133:1823–6.
47. MacNaughton M, Chalmers I, Dubowitz V, Dunn P, Grant A, McPherson K, et al. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. Br J Obstet Gynaecol 1993;100:516–23.
48. Rust OA, Atlas RO, Jones KJ, Benham BN, Balducci J. A randomized trial of cerclage versus no cerclage among patients with ultrasonographically detected second-trimester preterm dilatation of the internal os. Am J Obstet Gynecol 2000;183:830–5.
49. Rust OA, Atlas RO, Reed J, van Gaalen J, Balducci J. Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: why cerclage therapy may not help. Am J Obstet Gynecol 2001;185:1098–105.
50. Althuisius SM, Dekker GA, Hummel P, Bekedam DJ, van Geijn HP. Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 2001;185:1106–12.
51. Berghella V, Odibo AO, Tolosa JE. Cerclage for prevention of preterm birth in women with a short cervix found on transvaginal ultrasound examination: a randomized trial. Am J Obstet Gynecol 2004;191:1311–7.
52. Ezechi OC, Kalu BK, Nwokoro CA. Prophylactic cerclage for the prevention of preterm delivery. Int J Gynaecol Obstet 2004;85:283–4.
53. To MS, Alfirevic Z, Heath VC, Cicero S, Cacho AM, Williamson PR, et al. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial. Lancet 2004;363:1849–53.
54. Berghella V, Figueroa D, Szychowski JM, Owen J, Hankins GD, Iams JD, et al. 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length. Am J Obstet Gynecol 2010;202:351.e1–351.e6.
55. Otsuki K, Nakai A, Matsuda Y, Shinozuka N, Kawabata I, Makino Y, et al. Randomized trial of ultrasound-indicated cerclage in singleton women without lower genital tract inflammation. J Obstet Gynaecol Res 2016;42:148–57.
56. Goya M, Pratcorona L, Merced C, Rodó C, Valle L, Romero A, et al. Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. The Lancet 2012;379:1800–6.
57. Hui SY, Chor CM, Lau TK, Lao TT, Leung TY. Cerclage pessary for preventing preterm birth in women with a singleton pregnancy and a short cervix at 20 to 24 weeks: a randomized controlled trial. Am J Perinatol 2013;30:283–8.
58. Nicolaides KH, Syngelaki A, Poon LC, Picciarelli G, Tul N, Zamprakou A, et al. A randomized trial of a cervical pessary to prevent preterm singleton birth. N Engl J Med 2016;374:1044–52.
59. Keeler SM, Kiefer D, Rochon M, Quinones JN, Novetsky AP, Rust O. A randomized trial of cerclage vs. 17 alpha-hydroxyprogesterone caproate for treatment of short cervix. J Perinat Med 2009;37:473–9.
60. El-Gharib MN, El-Hawary TM. Matched sample comparison of intramuscular versus vaginal micronized progesterone for prevention of preterm birth. J Matern Fetal Neonatal Med 2013;26:716–9.
61. Maher MA, Abdelaziz A, Ellaithy M, Bazeed MF. Prevention of preterm birth: a randomized trial of vaginal compared with intramuscular progesterone. Acta Obstet Gynecol Scand 2013;92:215–22.
62. Bafghi AST, Bahrami E, Sekhavat L. Comparative study of vaginal versus intramuscular progesterone in the prevention of preterm delivery: a randomized clinical trial. Electron Physician 2015;7:1301.
63. The World Bank. Country and Lending Groups [internet]. [http://data.worldbank.org/about/country-and-lending-groups#High_income]. Accessed 19 November 2015.
64. Bender R, Friede T, Koch A, Kuss O, Schlattmann P, Schwarzer G, et al. Performing Meta-analyses in the Case of Very Few Studies. Seoul: Cochrane Colloquium, 2016.
65. Conde-Agudelo A, Romero R, Nicolaides K, Chaiworapongsa T, O'Brien JM, Cetingoz E, et al. Vaginal progesterone vs cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. Am J Obstet Gynecol 2013;208:42.e1–42.e18.